Mirae Asset Global Investments’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,726
Closed -$8.54K 1649
2025
Q1
$8.54K Buy
1,726
+7
+0.4% +$22 ﹤0.01% 1485
2024
Q4
$5.24K Buy
+1,719
New +$7.05K ﹤0.01% 1556
2024
Q2
Sell
-146,901
Closed -$1.35M 2474
2024
Q1
$1.35M Buy
146,901
+67,919
+86% +$319K ﹤0.01% 1380
2023
Q4
$337K Sell
78,982
-168,892
-68% -$519K ﹤0.01% 2148
2023
Q3
$972K Buy
247,874
+26,384
+12% +$173K ﹤0.01% 1535
2023
Q2
$2.24M Buy
221,490
+64,090
+41% +$679K ﹤0.01% 1162
2023
Q1
$1.61M Buy
157,400
+9,609
+7% +$110K ﹤0.01% 1320
2022
Q4
$1.38M Sell
147,791
-43,141
-23% -$609K ﹤0.01% 1327
2022
Q3
$2.78M Buy
190,932
+24,764
+15% +$368K 0.01% 1013
2022
Q2
$2.19M Buy
166,168
+95,062
+134% +$1.3M 0.01% 1113
2022
Q1
$1.21M Sell
71,106
-15,515
-18% -$263K ﹤0.01% 1288
2021
Q4
$2.22M Buy
+86,621
New +$2.7M ﹤0.01% 1101

Other funds holding TSVT

Mirae Asset Global Investments's TSVT Position: Q2 2025 in Review

Mirae Asset Global Investments sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,726 shares — an estimated $8.54K sold.

Mirae Asset Global Investments first reported a position in TSVT in Q4 2021 and held it in 12 quarters. The position peaked at $2.78M in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Mirae Asset Global Investments reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,726 2seventy bio shares in Q2 2025, an estimated $8.54K.
  • Mirae Asset Global Investments first reported a position in 2seventy bio in Q4 2021 and held it in 12 quarters.
  • Mirae Asset Global Investments's 2seventy bio position peaked at $2.78M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.